Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer

Miriam Ragle Aure1, Sandra Jernström1, Marit Krohn1

  • 1Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, 0310 Norway ; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, 0316 Norway.

Genome Medicine
|April 16, 2015
PubMed
Abstract

Insights

MicroRNAs significantly coordinate protein expression in breast cancer, revealing a complex regulatory network. This study maps these interactions, highlighting group action by microRNAs in cancer deregulation.

Area of Science:

  • Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • The precise role of microRNAs in breast cancer protein deregulation remains unclear.
  • Investigating the combined influence of microRNA and mRNA expression on protein levels is crucial for understanding cancer mechanisms.

Purpose of the Study:

  • To elucidate the regulatory relationships between microRNA and protein expression in breast cancer.
  • To construct a comprehensive interactome map of microRNA-protein associations.

Main Methods:

  • Developed a multilinear model to assess microRNA and mRNA effects on protein expression.
  • Applied Lasso penalized regression to identify simultaneous microRNA influences on protein levels.
  • Utilized three independent breast cancer datasets for robust analysis.

Main Results:

  • Generated a breast cancer interactome map detailing microRNA-protein associations.
  • Observed extensive coordination between microRNA and protein expression, with clustered interactions.
  • Validated findings in independent datasets and functionally confirmed specific microRNA-protein links in cell lines.

Conclusions:

  • A detailed map of microRNA and 105 cancer-associated protein co-expression in breast cancer was established.
  • Group action by multiple microRNAs is a prevalent mechanism for protein deregulation in breast cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.8K
MicroRNAs01:22

MicroRNAs

12.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K